Molecular Therapy: Methods and Clinical Development

Displaying 1 - 3 of 3
Wang, X., Moore, M. P., Shi, H., Miyata, Y., Donnelly, S. K., Radiloff, D. R., & Tabas, I. (2023). Hepatocyte-targeted siTAZ therapy lowers liver fibrosis in NASH diet-fed chimeric mice with hepatocyte-humanized livers. Molecular Therapy - Methods & Clinical Development, 31, 101165. https://doi.org/10.1016/j.omtm.2023.101165
Publication Date
Lydeard, J. R., Lin, M. I., Ge, H. G., Halfond, A., Wang, S., Jones, M. B., Etchin, J., Angelini, G., Xavier-Ferrucio, J., Lisle, J., Salvadore, K., Keschner, Y., Mager, H., Scherer, J., Hu, J., Mukherjee, S., & Chakraborty, T. (2023). Development of a gene edited next-generation hematopoietic cell transplant to enable acute myeloid leukemia treatment by solving off-tumor toxicity. Molecular Therapy - Methods & Clinical Development, 31, 101135. https://doi.org/10.1016/j.omtm.2023.101135
Publication Date
Strazza, M., Moore, E. K., Adam, K., Azoulay-Alfaguter, I., & Mor, A. (2022). Neutralization of the adaptor protein PAG by monoclonal antibody limits murine tumor growth. Molecular Therapy - Methods & Clinical Development, 27, 380–390. https://doi.org/10.1016/j.omtm.2022.10.012
Publication Date